friday glp 1 IRL Advertising Is Helping GLP-1 Brands Go Mainstream Long-Term Effects Of GLP-1s: Risks

One of the biggest frustrations for patients is that GLP-1 side effects can overlap with hypothyroid symptoms

Side-by-Side Comparison Parameter Receptors Cagrilintide AMY1R/2R/3R + CTR Semaglutide GLP-1R Tirzepatide GLP-1R + GIPR Retatrutide GLP-1R + GIPR + Glucagon-R Parameter Half-life Cagrilintide ~7-8 days Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Parameter Dosing frequency Cagrilintide Once weekly Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Parameter Max studied dose Cagrilintide 4.5 mg/week (mono) Semaglutide 2.4 mg/week Tirzepatide 15 mg/week Retatrutide 12 mg/week Parameter Peak monotherapy weight loss Cagrilintide 11.8% at 68 wk Semaglutide 14.9-17% at 68 wk Tirzepatide 22.5% at 72 wk Retatrutide ~24% at 48 wk Parameter FDA status (June 2026) Cagrilintide Investigational Semaglutide Approved (2021) Tirzepatide Approved (2023) Retatrutide Investigational Parameter HbA1c reduction (T2D) Cagrilintide ~0.9 pp mono

However, there is little to no evidence to support these claims

This glow-inducing face mask is formulated with a brightening power trio of Glutathione, Niacinamide & a 13-Peptide Complex to correct skin dryness, dullness, dark spots & discoloration

Why Choose Our BPC-157 5mg + TB-500 5mg (Blend), 10mg

Regardless of species, the UMNs of a broad spectrum of ALS patients and corticospinal motor neurons (CSMN